CADL Candel Therapeutics: Bozor kapitallashuvining balans qiymatiga nisbati

candeltx.com (CADL) - korporativ logo

Saratonga qarshi terapiya vositalarini ishlab chiquvchi Candel Therapeutics (CADL) kompaniyasining narxlar dinamikasi grafigi 5.00 darajasidagi tebranishlarni namoyish etmoqda. Ushbu tendentsiya laboratoriyalarda ekologik toza filtrlarning joriy etilishi va dori vositalarini sinovdan o'tkazishning yakuniy bosqichlariga bo'lgan kritik kapital bog'liqligini aks ettiradi, bu esa moliyalashtirish yetishmovchiligi xavfini tug'diradi. Bundan tashqari, biznes Osiyodan xomashyo importi bilan bog'liq qiyinchiliklar va xalqaro patent mojarolari bosimi ostida qolmoqda.

Candel Therapeutics, Inc. (CADL) - Bozor kapitallashuvining balans qiymatiga nisbati 04.07.2022dan 28.10.2026gacha

CADL (Candel Therapeutics): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- narx va narxlar bo'yicha konsensus prognoz:
Narx grafigi candeltx.com|CADL - Maqsadli narxlar grafigi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi Candel|CADL - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Candel Therapeutics|CADL - Balans kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati candeltx.com|CADL - Biznesning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Candel Therapeutics|CADL - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati candeltx.com|CADL - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans kapitallashuviga nisbati Candel
Fundamental baholash:CADL (Candel Therapeutics Inc.)
Candel Therapeutics tayyor mahsulotlari

Ushbu koeffitsient biznesning bozor qiymatining uning sof kapitaliga nisbatini aks ettirib, birja narxining real aktivlarga nisbatan qanchalik hadda qimmat yoki arzon baholanganini o'lchaydi. Bozor baholovining balans qiymatidan yuqori ekanligini tahlil qilish Candel Therapeutics (CADL) kompaniyasining onko-immunoterapiya bozoridagi kengayishiga oid investitsiya kutsivlarini baholash imkonini beradi, bu bozorda dori vositalarining yuqori samaradorligi kompaniya qiymatining joriy kapitalidan yuqoriga o'sishi uchun potentsial yaratadi.

Asosiy raqobatchilar

BeiGene Ltd (ONC) - Bozor qiymatining balans qiymatiga nisbati|halozyme.com (HALO) - Bozor qiymatining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati RVMD|Kapitallashuvning sof aktivlarga nisbati Ascentage Pharma Group International|Bozor kapitallashuvining balans qiymatiga nisbati CGON|Bozor kapitallashuvining balans qiymatiga nisbati URGN (UroGen Pharma Corp)|BCAX - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati personalis.com PSNL|ERAS: Bozor kapitallashuvining balans qiymatiga nisbati|DCTH - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati YMAB|AURA (Aura Corp) - Bozor qiymatining balans qiymatiga koeffitsiyenti|ARAY - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati SELLAS Life Sciences Group Inc. (SLS)|Actuate Therapeutics (ACTU) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati Citius Oncology Inc. (CTOR)|TuHURA Biosciences - Bozor kapitallashuvining balans qiymatiga nisbati|TARA - Kapitallashuvning sof aktivlarga nisbati|Fate Therapeutics, Inc. - Kapitallashuvning sof aktivlarga nisbati|WHWK: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati tscan.com TCRX|Champions Oncology, Inc. (CSBR) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati XBIT (XBiotech Inc)|Bozor qiymatining balans qiymatiga koeffitsiyenti CEL-SCI Corp|Bozor kapitallashuvining balans qiymatiga nisbati OSTX (OS Therapies Incorporated)|Kapitallashuvning sof aktivlarga nisbati Radiopharm Theranostics Ltd (RADX)|Bozor kapitallashuvining balans qiymatiga nisbati ARTV (Artiva Biotherapeutics)|Adlai Nortye Ltd - Bozor kapitallashuvining balans qiymatiga nisbati|Veru Pharma (VERU) - Bozor qiymatining balans qiymatiga nisbati|TPST - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati xiliotx.com|Renovaro (RENB) - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati MURA (Mural Oncology PLC)|Bozor qiymatining balans qiymatiga koeffitsiyenti KAPA|Bozor qiymatining balans qiymatiga nisbati OnKure Therapeutics Inc (OKUR)|Bozor qiymatining balans qiymatiga nisbati w2.cytomed.sg GDTC|Kapitallashuvning sof aktivlarga nisbati Curis|APLM - Balans qiymatiga nisbatan bozor qiymati|Kapitallashuvning sof aktivlarga nisbati Tharimmune THAR|ADVB - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati Genprex, Inc GNPX|Calidi Biotherapeutics, Inc. (CLDI) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati SBFM (Sunshine Biopharma)|Bozor qiymatining balans qiymatiga koeffitsiyenti XBIO|Salarius Pharmaceuticals, Inc. (SLRX) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Purple Biotech Ltd (PPBT)|Bozor kapitallashuvining balans qiymatiga nisbati AONC (American Oncology Network, Inc.)|BeiGene Ltd - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Checkpoint Therapeutics|ELEV - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati ICAD|Bozor qiymatining balans qiymatiga koeffitsiyenti Ikena Oncology|NTBL (Notable Labs Inc.) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Viracta (VIRX)|Kapitallashuvning sof aktivlarga nisbati MorphoSys AG|Bozor kapitallashuvining balans qiymatiga multiplikatori nayabiosciences.com (NAYA)|Bozor kapitallashuvining balans qiymatiga nisbati AAPGV